Clinical Research Advancement

Insights & Publications | Articles

Excerpt from from the published article “Successes and Challenges in Clinical Trial Recruitment: The Experience of a New Study Team”

Recruitment and Retention in Global Clinical Research

Recruitment and retention of participants are central to the success of global clinical trials. Major multinational studies frequently experience delays or fail due to under-enrollment and poor retention, highlighting the necessity for sophisticated, globalized recruitment services.

Recruitment is Critical to The Success of Global Clinical Trials:

Direct Impact on Timelines and ROI: 86% of international clinical trials fail to meet recruitment targets within planned timelines, causing delays in drug development and increased operational costs.

Data Power and Validity: Underpowered studies due to inadequate enrollment or high dropout rates weaken results and may limit regulatory approval.

Global Diversity and Real-World Relevance: Trials lacking geographic and demographic diversity produce less generalizable findings, which can impede both regulatory success and health equity.

Why Global Recruitment Partners Are Essential

  • Access to Diverse Populations: Global recruitment partners enable targeting across regions and underserved groups, strengthening trial diversity and scientific impact.
  • Expedited Enrollment: Leveraging broad international networks and advanced technology, they accelerate participant enrollment and minimize costly delays.
  • Regulatory Expertise: They provide crucial guidance on navigating complex, region-specific regulatory requirements in multi-country clinical research.
  • Multimodal Outreach and Retention: Their expertise in digital, community, and provider engagement drives better patient participation and delivers culturally attuned support for improved retention.

Are you ready to accelerate your clinical research? Partnering with Clinical Research Advancement’s global recruitment services is the key to faster, more diverse, and highly impactful trials. By leveraging extensive networks, advanced digital tools, and in-depth local insights, we enable expedited enrollment, seamless regulatory navigation, and improved participant retention across the globe.

Collaborating with specialized global recruitment partners helps reduce costly delays, broaden patient diversity, and bring therapies to market more quickly. Now is the time to invest in strategic, scalable, and innovative solutions that drive clinical trial success.

 Let’s unlock the future of clinical research together—connect with Clinical Research Advancement’s experts today and transform your trial outcomes. (Man Hung et al., 2024).

Reference:
Man Hung, A. Mohajeri, K. Almpani, G. Carberry, J. F. Wisniewski, K. Janes, … & F. W. Licari. (2024). Successes and challenges in clinical trial recruitment: The experience of a new study team. 

Medical Sciences (Basel), 12(3), 39.

Read the full article on PMC

#ClinicalResearchAdvancement #InnovateClinicalResearch #PatientRecruitment #ClinicalTrialInnovation #TrialRetention #ResearchOpportunities

Clinical Research Advancement
Insights & Publications

Operational Strategies for Clinical Trials in Africa

July 25, 2020

In a dramatic reversal of longstanding trends, cancer now kills more Africans than malaria.

Differences and Similarities in Presentation and Management Patterns in Patients With Hepatocellular Carcinoma (HCC) Across Hong Kong, Singapore and Thailand

February 10, 2020

Pierce K. H. Chow1, Yen Chia², Bhuvaneswari Ramaswamy², Jean-Francois Baladi², Arlene Acorda Dalin3, Kimi Shaoqing Xu3, Yvanka Marie Gilliam3, Regina Gowindah3, Yirong Chen3, Shikha Singh3, Vince Grillo3

Differences in presentation and management patterns in patients with hepatocellular carcinoma (HCC): Data from HCC registry in Asia.

January 29, 2019

Authors: Pierce K. H. Chow, Lequn Li, Jiangtao Li, Fan Jia, Hee-Jee Wang, Kiyoshi Hasegawa, Jin-Mo Yang, Poh-Seng Tan, Shukui Qin, Kwang-Hyub Han, Brian Goh, Ho Seong Han, Junji Furuse, Xu Zhu, Joanna Zhi Jie Ling, and Mihir Gandhi

Differences in presentation and management patterns in patients with hepatocellular carcinoma (HCC) between China and Singapore: Initial data from the HCC Registry in Asia.

February 10, 2018

Authors: Pierce K. H. Chow, Lequn Li, Jiangtao Li, Poh-Seng Tan, Fan Jia, Shukui Qin, Yvanka Marie Gilliam, Joanna Zhi Jie Ling, and Mihir Gandhi, on behalf of Asia-Pacific Hepatocellular Carcinoma (AHCC) Trials Group

Clinical Research Advancement
Articles

Breaking Through Clinical Trial Barriers: When Recruitment Plans fail.

March 27, 2026

Many studies fall behind because initial enrollment assumptions don’t reflect real‑world patient flow, competing trials, or site capacity.

Why Africa Is the Next Big Frontier for Clinical Trials 2025–2030 Predictions

February 24, 2026

Africa is moving from “promising” to pivotal in clinical research.

Successes and Challenges in Clinical Trial Recruitment: The Experience of a New Study Team

February 10, 2026

Participant recruitment is one of the most challenging aspects of a clinical trial, directly impacting both the study’s duration and the quality of its results.

Precision, Relevance and Prediction: The Future of Clinical Trial Recruitment

January 22, 2026

The landscape of clinical trials is undergoing a profound transformation.

De-risking drug development: Ex-US clinical trials as a strategic advantage in 2025

September 9, 2025

The industry faces a significant dilemma in 2025 as it strives to maintain innovation amid growing global instability.

Improving access to innovative medicines in Africa starts with clinical trials

July 24, 2025

The global health community has long called for innovation that delivers impact where it is needed most.

Clinical Research Advancement Publications

ESMO Asia publication 2020, Annals of Oncology

ASCO GI PUBLICATION 2019_JCO

ASCO PUBLICATION 2018_JCO

“Successes and Challenges in Clinical Trial Recruitment: The Experience of a New Study Team.”

Recruitment and Retention in Global Clinical Research

Recruitment and retention of participants are central to the success of global clinical trials. Major multinational studies frequently experience delays or fail due to under-enrollment and poor retention, highlighting the necessity for sophisticated, globalized recruitment services.

Recruitment is Critical to The Success of Global Clinical Trials:

Direct Impact on Timelines and ROI: 86% of international clinical trials fail to meet recruitment targets within planned timelines, causing delays in drug development and increased operational costs.

Data Power and Validity: Underpowered studies due to inadequate enrollment or high dropout rates weaken results and may limit regulatory approval.

Global Diversity and Real-World Relevance: Trials lacking geographic and demographic diversity produce less generalizable findings, which can impede both regulatory success and health equity.

Why Global Recruitment Partners Are Essential

  • Access to Diverse Populations: Global recruitment partners enable targeting across regions and underserved groups, strengthening trial diversity and scientific impact.
  • Expedited Enrollment: Leveraging broad international networks and advanced technology, they accelerate participant enrollment and minimize costly delays.
  • Regulatory Expertise: They provide crucial guidance on navigating complex, region-specific regulatory requirements in multi-country clinical research.
  • Multimodal Outreach and Retention: Their expertise in digital, community, and provider engagement drives better patient participation and delivers culturally attuned support for improved retention.

Are you ready to accelerate your clinical research? Partnering with Clinical Research Advancement’s global recruitment services is the key to faster, more diverse, and highly impactful trials. By leveraging extensive networks, advanced digital tools, and in-depth local insights, we enable expedited enrollment, seamless regulatory navigation, and improved participant retention across the globe.

Collaborating with specialized global recruitment partners helps reduce costly delays, broaden patient diversity, and bring therapies to market more quickly. Now is the time to invest in strategic, scalable, and innovative solutions that drive clinical trial success.

 Let’s unlock the future of clinical research together—connect with Clinical Research Advancement’s experts today and transform your trial outcomes. (Man Hung et al., 2024).

Reference:
Man Hung, A. Mohajeri, K. Almpani, G. Carberry, J. F. Wisniewski, K. Janes, … & F. W. Licari. (2024). Successes and challenges in clinical trial recruitment: The experience of a new study team. 

Medical Sciences (Basel), 12(3), 39.

Read the full article on PMC